Cargando…
Prevalence of non-Alcoholic Fatty Liver Disease and Associated Factors in Patients with Moderate or Severe Hemophilia: A Multicenter-Based Study
INTRODUCTION: Liver health is essential for persons with hemophilia (PWH) in order to maintain access to new therapies, such as gene therapy. Non-alcoholic fatty liver disease (NAFLD) is seldom reported in the hemophilia population. The study aimed to investigate the prevalence of NAFLD and associat...
Autores principales: | Shen, Ming-Ching, Chiou, Shyh-Shin, Chou, Sheng-Chieh, Weng, Te-Fu, Lin, Ching-Yeh, Wang, Jiaan-Der, Lee, Shou-Wu, Peng, Ching-Tien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520174/ https://www.ncbi.nlm.nih.gov/pubmed/36163682 http://dx.doi.org/10.1177/10760296221128294 |
Ejemplares similares
-
Acquired Hemophilia A: A Retrospective Multicenter Analysis of 42 Patients
por: Liu, Yanhui, et al.
Publicado: (2023) -
Phase 3 Clinical Trial: Perioperative Use of Nonacog Gamma, a Recombinant Factor IX, in Previously Treated Patients With Moderate/Severe Hemophilia B
por: Windyga, Jerzy, et al.
Publicado: (2020) -
Current animal models of hemophilia: the state of the art
por: Yen, Ching-Tzu, et al.
Publicado: (2016) -
Absence of Effect of Emicizumab on D-Dimer Concentrations in Adult
Patients with Severe Hemophilia A
por: Iarossi, Michael, et al.
Publicado: (2022) -
Comorbidities of cardiovascular disease and cancer in hemophilia patients
por: Wang, Jiaan-Der
Publicado: (2016)